TrialDrugs in R&D2012

Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.

Kari R Nations et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.